SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-043315
Filing Date
2022-11-28
Accepted
2022-11-28 17:00:52
Documents
5
Period of Report
2022-12-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20005664x2_def14a.htm DEF 14A 667164
2 logo_neurobo.jpg GRAPHIC 50705
3 logo_neurobox1.jpg GRAPHIC 39236
4 ny20005664x2_pc-1.jpg GRAPHIC 755542
5 ny20005664x2_pc-2.jpg GRAPHIC 434125
  Complete submission text file 0001140361-22-043315.txt   2429710
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37809 | Film No.: 221426368
SIC: 2834 Pharmaceutical Preparations